204 related articles for article (PubMed ID: 26719157)
1. Negative association between GATA3 and fascin could predict relapse-free and overall survival in patients with breast cancer.
Min KW; Kim DH; Do SI; Chae SW; Kim K; Sohn JH; Pyo JS; Lee HJ; Kim DH; Oh S; Choi SH; Park YL; Park CH; Kim EK; Kwon MJ; Seo J; Moon KM
Virchows Arch; 2016 Apr; 468(4):409-16. PubMed ID: 26719157
[TBL] [Abstract][Full Text] [Related]
2. Expression Pattern of Smad4/GATA3 as a Predictor of Survival in Invasive Ductal Carcinoma of the Breast.
Min KW; Kim DH; Do SI; Chae SW; Kim K; Sohn JH; Lee HJ; Do IG; Pyo JS; Kim Y; Kim DH; Yang JH; Lee SJ; Oh YH; Oh S; Choi SH; Park YL; Park CH; Kim EK; Kwon MJ; Seo J
Pathobiology; 2017; 84(3):130-138. PubMed ID: 28288473
[TBL] [Abstract][Full Text] [Related]
3. Strong association of fascin expression with triple negative breast cancer and basal-like phenotype in African-American women.
Esnakula AK; Ricks-Santi L; Kwagyan J; Kanaan YM; DeWitty RL; Wilson LL; Gold B; Frederick WA; Naab TJ
J Clin Pathol; 2014 Feb; 67(2):153-60. PubMed ID: 23986556
[TBL] [Abstract][Full Text] [Related]
4. Fascin expression is related to poor survival in gastric cancer.
Kim SJ; Kim DC; Kim MC; Jung GJ; Kim KH; Jang JS; Kwon HC; Kim YM; Jeong JS
Pathol Int; 2012 Dec; 62(12):777-84. PubMed ID: 23252866
[TBL] [Abstract][Full Text] [Related]
5. GATA3 transcription factor abrogates Smad4 transcription factor-mediated fascin overexpression, invadopodium formation, and breast cancer cell invasion.
Sun J; He H; Pillai S; Xiong Y; Challa S; Xu L; Chellappan S; Yang S
J Biol Chem; 2013 Dec; 288(52):36971-82. PubMed ID: 24235142
[TBL] [Abstract][Full Text] [Related]
6. The expression of fascin, an actin-bundling motility protein, correlates with hormone receptor-negative breast cancer and a more aggressive clinical course.
Yoder BJ; Tso E; Skacel M; Pettay J; Tarr S; Budd T; Tubbs RR; Adams JC; Hicks DG
Clin Cancer Res; 2005 Jan; 11(1):186-92. PubMed ID: 15671545
[TBL] [Abstract][Full Text] [Related]
7. Association of Fascin and matrix metalloproteinase-9 expression with poor prognostic parameters in breast carcinoma of Egyptian women.
Youssef NS; Hakim SA
Diagn Pathol; 2014 Jul; 9():136. PubMed ID: 24993803
[TBL] [Abstract][Full Text] [Related]
8. Characterisation of GATA3 expression in invasive breast cancer: differences in histological subtypes and immunohistochemically defined molecular subtypes.
Shaoxian T; Baohua Y; Xiaoli X; Yufan C; Xiaoyu T; Hongfen L; Rui B; Xiangjie S; Ruohong S; Wentao Y
J Clin Pathol; 2017 Nov; 70(11):926-934. PubMed ID: 28428285
[TBL] [Abstract][Full Text] [Related]
9. GATA3 expression in advanced breast cancer: prognostic value and organ-specific relapse.
McCleskey BC; Penedo TL; Zhang K; Hameed O; Siegal GP; Wei S
Am J Clin Pathol; 2015 Nov; 144(5):756-63. PubMed ID: 26486740
[TBL] [Abstract][Full Text] [Related]
10. The impact of the effectiveness of GATA3 as a prognostic factor in breast cancer.
Fararjeh AS; Tu SH; Chen LC; Liu YR; Lin YK; Chang HL; Chang HW; Wu CH; Hwang-Verslues WW; Ho YS
Hum Pathol; 2018 Oct; 80():219-230. PubMed ID: 29902578
[TBL] [Abstract][Full Text] [Related]
11. GATA3 expression and its relationship with clinicopathological parameters in invasive breast carcinomas.
Cakir A; Isik Gonul I; Ekinci O; Cetin B; Benekli M; Uluoglu O
Pathol Res Pract; 2017 Mar; 213(3):227-234. PubMed ID: 28215639
[TBL] [Abstract][Full Text] [Related]
12. Combined Fascin-1 and MAP17 Expression in Breast Cancer Identifies Patients with High Risk for Disease Recurrence.
Tampaki EC; Tampakis A; Nonni A; von Flüe M; Patsouris E; Kontzoglou K; Kouraklis G
Mol Diagn Ther; 2019 Oct; 23(5):635-644. PubMed ID: 31273628
[TBL] [Abstract][Full Text] [Related]
13. Fascin is a predictor for invasiveness and recurrence of urothelial carcinoma of bladder.
Bi J; Chen X; Zhang Y; Li B; Sun J; Shen H; Kong C
Urol Oncol; 2012 Sep; 30(5):688-94. PubMed ID: 20888270
[TBL] [Abstract][Full Text] [Related]
14. Fascin expression is increased in metastatic lesions but does not correlate with progression nor outcome in melanoma.
Ma Y; Faller WJ; Sansom OJ; Brown ER; Doig TN; Melton DW; Machesky LM
Melanoma Res; 2015 Apr; 25(2):169-72. PubMed ID: 25535872
[TBL] [Abstract][Full Text] [Related]
15. Smad4/Fascin index is highly prognostic in patients with diffuse type EBV-associated gastric cancer.
Son BK; Kim DH; Min KW; Kim EK; Kwon MJ
Pathol Res Pract; 2018 Apr; 214(4):475-481. PubMed ID: 29572117
[TBL] [Abstract][Full Text] [Related]
16. The prognostic relevance of fascin expression in human gastric carcinoma.
Hashimoto Y; Shimada Y; Kawamura J; Yamasaki S; Imamura M
Oncology; 2004; 67(3-4):262-70. PubMed ID: 15557788
[TBL] [Abstract][Full Text] [Related]
17. Correlation and prognostic value of SIRT1 and Notch1 signaling in breast cancer.
Cao YW; Li WQ; Wan GX; Li YX; Du XM; Li YC; Li F
J Exp Clin Cancer Res; 2014 Nov; 33(1):97. PubMed ID: 25420528
[TBL] [Abstract][Full Text] [Related]
18. Fascin expression predicts lymph node metastasis and worse survival in small intestinal carcinoma.
Gu MJ; Kim JY; Park JB
Pathology; 2014 Jan; 46(1):21-4. PubMed ID: 24300716
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of interferon regulating factor 4 (IRF4) in node-negative breast cancer.
Heimes AS; Madjar K; Edlund K; Battista MJ; Almstedt K; Gebhard S; Foersch S; Rahnenführer J; Brenner W; Hasenburg A; Hengstler JG; Schmidt M
J Cancer Res Clin Oncol; 2017 Jul; 143(7):1123-1131. PubMed ID: 28251349
[TBL] [Abstract][Full Text] [Related]
20. The role of GATA3 in breast carcinomas: a review.
Asch-Kendrick R; Cimino-Mathews A
Hum Pathol; 2016 Feb; 48():37-47. PubMed ID: 26772397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
